Approval · Notice of Compliance 31570 · 2023
VELTASSA: Notice of Compliance 31570
Issued September 6, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31570
- Date
- September 6, 2023
- Company
- Vifor Fresenius Medical Care Renal Pharma LtdSt Gallen, St Gallen, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph. Product Monograph reformatted to the Master Template. Update to the package insert. Update to the inner and outer labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELTASSA | Not yet assigned | — |
Medicinal ingredients
- PATIROMER SORBITEX CALCIUM 8.4 G per SACHET
- PATIROMER SORBITEX CALCIUM 16.8 G per SACHET
- PATIROMER SORBITEX CALCIUM 25.2 G per SACHET